Pahl A - Search Results

1

Protection against progressive leishmaniasis by IFN-beta.

Mattner J, Wandersee-Steinhäuser A, Pahl A, Röllinghoff M, Majeau GR, Hochman PS, Bogdan C. Mattner J, et al. Among authors: pahl a. J Immunol. 2004 Jun 15;172(12):7574-82. doi: 10.4049/jimmunol.172.12.7574. J Immunol. 2004. PMID: 15187137

2

Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells.

Lohoff M, Duncan GS, Ferrick D, Mittrücker HW, Bischof S, Prechtl S, Röllinghoff M, Schmitt E, Pahl A, Mak TW. Lohoff M, et al. Among authors: pahl a. J Exp Med. 2000 Aug 7;192(3):325-36. doi: 10.1084/jem.192.3.325. J Exp Med. 2000. PMID: 10934221 Free PMC article.

3

Host-cell cyclophilin is important for the intracellular replication of Leishmania major.

Hoerauf A, Rascher C, Bang R, Pahl A, Solbach W, Brune K, Röllinghoff M, Bang H. Hoerauf A, et al. Among authors: pahl a. Mol Microbiol. 1997 Apr;24(2):421-9. doi: 10.1046/j.1365-2958.1997.3401716.x. Mol Microbiol. 1997. PMID: 9159527 Free article.

4

Quantitative detection of Borrelia burgdorferi by real-time PCR.

Pahl A, Kühlbrandt U, Brune K, Röllinghoff M, Gessner A. Pahl A, et al. J Clin Microbiol. 1999 Jun;37(6):1958-63. doi: 10.1128/JCM.37.6.1958-1963.1999. J Clin Microbiol. 1999. PMID: 10325354 Free PMC article.

5

Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells.

Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M. Veldman C, et al. Among authors: pahl a. J Immunol. 2006 Mar 1;176(5):3215-22. doi: 10.4049/jimmunol.176.5.3215. J Immunol. 2006. PMID: 16493082

6

miR-9 enhances IL-2 production in activated human CD4(+) T cells by repressing Blimp-1.

Thiele S, Wittmann J, Jäck HM, Pahl A. Thiele S, et al. Among authors: pahl a. Eur J Immunol. 2012 Aug;42(8):2100-8. doi: 10.1002/eji.201142203. Eur J Immunol. 2012. PMID: 22585398 Free article.

7

Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages.

Hinz B, Brune K, Rau T, Pahl A. Hinz B, et al. Among authors: pahl a. Pharm Res. 2001 Feb;18(2):151-6. doi: 10.1023/a:1011020132140. Pharm Res. 2001. PMID: 11405284

8

Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787.

Pahl A, Zhang M, Török K, Kuss H, Friedrich U, Magyar Z, Szekely J, Horvath K, Brune K, Szelenyi I. Pahl A, et al. J Pharmacol Exp Ther. 2002 May;301(2):738-46. doi: 10.1124/jpet.301.2.738. J Pharmacol Exp Ther. 2002. PMID: 11961080

9

Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.

Hinz B, Brune K, Pahl A. Hinz B, et al. Among authors: pahl a. Biochem Biophys Res Commun. 2000 May 10;271(2):353-7. doi: 10.1006/bbrc.2000.2632. Biochem Biophys Res Commun. 2000. PMID: 10799301

10

Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice.

Gühring H, Görig M, Ates M, Coste O, Zeilhofer HU, Pahl A, Rehse K, Brune K. Gühring H, et al. Among authors: pahl a. J Neurosci. 2000 Sep 1;20(17):6714-20. doi: 10.1523/JNEUROSCI.20-17-06714.2000. J Neurosci. 2000. PMID: 10964977 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters